Wanlu Li Selected Research

stattic

1/2019	CRISPR-Cas9 mediated CD133 knockout inhibits colon cancer invasion through reduced epithelial-mesenchymal transition.
1/2018	Activated STAT3 may participate in tumor progression through increasing CD133/survivin expression in early stage of colon cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wanlu Li Research Topics

Disease

5	Neoplasms (Cancer) 05/2020 - 10/2013
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020 - 01/2017
4	Ischemic Stroke 12/2021 - 01/2019
4	Colonic Neoplasms (Colon Cancer) 05/2020 - 01/2017
4	Brain Ischemia (Cerebral Ischemia) 05/2020 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 01/2017
2	Stroke (Strokes) 12/2021 - 01/2019
2	Reperfusion Injury 10/2021 - 10/2019
2	Inflammation (Inflammations) 10/2021 - 01/2020
2	Ischemia 10/2021 - 05/2018
2	Brain Infarction 01/2020 - 01/2017
2	Infarction (Infarctions) 01/2019 - 01/2017
1	Infections 11/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2022
1	Hyperuricemia 01/2022
1	Atrophy 12/2021
1	Necrosis 09/2021
1	COVID-19 01/2021
1	Familial Primary Pulmonary Hypertension 01/2021
1	Pathologic Processes 06/2020
1	Colitis-Associated Neoplasms 05/2020
1	Acidosis 05/2020
1	Brain Injuries (Brain Injury) 05/2020
1	Hyperglycemia 01/2020
1	Brain Edema (Cerebral Edema) 01/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 05/2018
1	AIDS-Related Complex (ARC) 01/2018
1	Carcinogenesis 01/2018
1	Lymphatic Metastasis 01/2017

Drug/Important Bio-Agent (IBA)

2	Interleukin-4 (Interleukin 4)IBA 11/2022 - 09/2021
2	LigandsIBA 09/2021 - 05/2020
2	Interleukin-6 (Interleukin 6)IBA 09/2021 - 05/2018
2	Neuroprotective AgentsIBA 05/2020 - 01/2019
2	Tight Junction ProteinsIBA 01/2020 - 05/2018
2	statticIBA 01/2019 - 01/2018
2	SurvivinIBA 01/2018 - 01/2017
1	GoldIBA 11/2022
1	SilverIBA 11/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2022
1	Uric Acid (Urate)IBA 01/2022
1	Netrin-1IBA 12/2021
1	allicinIBA 10/2021
1	Transcription Factors (Transcription Factor)IBA 09/2021
1	InflammasomesIBA 09/2021
1	p38 Mitogen-Activated Protein KinasesIBA 09/2021
1	2,2',4,4'-tetrabromodiphenyl etherIBA 09/2021
1	Interleukin-13IBA 09/2021
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 09/2021
1	Interleukin-10 (Interleukin 10)IBA 09/2021
1	NF-kappa B (NF-kB)IBA 09/2021
1	Acetylcysteine (Siran)FDA LinkGeneric 09/2021
1	NitrogenIBA 01/2021
1	Urea (Carbamide)FDA LinkGeneric 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 06/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2020
1	Dextrans (Dextran)FDA Link 05/2020
1	Interferon Type IIBA 05/2020
1	AzoxymethaneIBA 05/2020
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 05/2020
1	Protons (Proton)IBA 05/2020
1	ChannelrhodopsinsIBA 05/2020
1	OccludinIBA 01/2020
1	Streptozocin (Streptozotocin)FDA Link 01/2020
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	3-n-butylphthalide (butylphthalide)IBA 10/2019
1	CytokinesIBA 05/2018
1	Immunoglobulin G (IgG)IBA 05/2018
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2018
1	Biological ProductsIBA 01/2018
1	NickelIBA 01/2018
1	InterleukinsIBA 01/2018
1	octaethylporphyrinIBA 01/2018
1	FullerenesIBA 01/2018
1	sepantroniumIBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Fluorouracil (Carac)FDA LinkGeneric 01/2017
1	ChromiumIBA 10/2013
1	Heavy MetalsIBA 10/2013

Therapy/Procedure

3	Transplantation 12/2021 - 01/2017
3	Therapeutics 05/2020 - 01/2017
2	Lasers (Laser) 01/2019 - 12/2017
1	Drug Therapy (Chemotherapy) 01/2021
1	Synchrotrons 10/2019
1	Mesenchymal Stem Cell Transplantation 05/2018
1	Optical Fibers 12/2017